We don't know exactly what causes multiple sclerosis, but it is believed to be some combination of immunologic, environmental, infectious, and/or genetic factors. Some theories have been proposed, though there is not enough evidence to establish any one cause. Theories as to what causes MS inc...
Most cases appear sporadically but some are familial, usually inherited in an autosomal dominant pattern. It is postulated that the disease results from the combination of multiple pathogenic mechanisms, which affect not only motor neurons but also non-neuronal neighboring cells. Together with the ...
Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing. Furthermore, Eisai has initiated a...
What skin disorder might be found in a person who is elderly, debilitated, or paralyzed? A person who has motor aphasia as a result of damage to Broca's area, has difficulty doing what? What disease would occur if a person inherited two defec...
The former is expected to be driven by inherited or polygenic risk and, therefore, associated with individuals closer to the threshold (and thus more male-biased under the DT-LTM), whereas the latter is predicted to be associated with highly penetrant genetic variants (less male-biased). Most...
medical researchers and practitioners are still discovering new long-term effects. Long-term effects can include the development of cancer in a wide variety of organs and body systems, organ disease, infertility, and hormone problems. Type-2 diabetes, multiple sclerosis, Parkinson's disease, porphyri...
cancer.dementia, including Alzheimer's disease. advanced lung, heart, kidney and liver disease. stroke and other neurological diseases, including motor neurone disease and multiple sclerosis. What diseases are transmissible? 9 Highly Contagious Diseases You Should Know About ...
Today, Biogen has a leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and developed the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is also comm...
Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing. ...
Today, Biogen has a leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and developed the first and only approved treatment to address ...